Open Access<p>SLC39A4 as a Novel Prognosis Marker Promotes Tumor Progression in Esophageal Squamous Cell Carcinoma</p>
Author(s) -
Chenmei Xia,
Xia Chen,
Jun Li,
Peng Chen
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s245094
Subject(s) - medicine , gene knockdown , oncology , cisplatin , immunohistochemistry , esophageal squamous cell carcinoma , cancer research , biomarker , cancer , metastasis , cell culture , biology , chemotherapy , biochemistry , genetics
Solute carrier family 39 member 4 (SLC39A4) has been reported to play an oncogenic role in several cancers. However, the role of SLC39A4 in esophageal squamous cell carcinoma (ESCC) remains unclear. In this study, we aimed to explore the clinical significance and function of SLC39A4 in ESCC.